Presentation

The Genomics and Biomedicine research group (GXB) at the University of Vigo is a multidisciplinary team equipped to tackle ambitious new challenges in biomedical and genomic research.

GXB is currently coordinated by David Posada and includes principal investigators Diana Valverde, Carmen Rodríguez, Miguel Arenas, Iria Fernández-Silva, and María Mayán, along with multiple postdoctoral researchers, graduate students, and technical staff.

Our group is part of the Center for Nanomaterials and Biomedicine (CINBIO) at the University of Vigo, a Singular Research Center recognized by the Galician Government.

Our research is funded by the University of Vigo, the Consellería de Cultura, Educación e Ordenación Universitaria of the Galician Government, the Ministerio de Ciencia, Innovación y Universidades of the Spanish Government, and the European Union.

Research

The Genomics and Biomedicine Group (GXB) carries out its research in three areas: genomics of diseases and pathogens, molecular biology applied to biomedicine, and nanomaterials in biomedicine.

In the area of genomics of diseases and pathogens, the GXB studies cancer genomics through single-cell analysis and liquid biopsy, the molecular evolution of human pathogenic viruses such as HIV-1, SARS-CoV-2, and CCHFV, including resistance to antiretrovirals, and evolutionary genomics applied to the conservation of biological resources, with European and national funding and collaborations with Galician hospitals.

In the area of molecular biology applied to biomedicine, research focuses on the genetic basis of rare ciliary diseases and pulmonary arterial hypertension, supported by ISCIII-FIS, as well as on the mechanisms of aging in cancer and osteoarthritis, seeking new therapeutic targets and biomarkers.

In the area of nanomaterials for biomedicine, GXB designs green-chemistry nanomaterials with antitumor and antimicrobial applications and develops drug-delivery systems and mRNA therapies against cancer.

People

Principal investigators

Postdoctoral researchers

  • Joao Alves (mail)
  • Nuria Estévez (mail)
  • Noelia González-Ballesteros (mail)
  • Loretta de Chiara (mail)
  • Valeria Zoni (mail)
  • Carlos López-Solarat (mail)
  • Laura Tomás (mail)
  • Kylie Chen (mail)
  • Luis Daniel González (mail)
  • Adrián Cordido (mail)
  • Soumadipta Mazumdar (mail)

PhD students

  • Sarai Moledo (mail)
  • Laura Ceide (mail)
  • Alfonso Bravo (mail)
  • Sara Vila (mail)
  • Elena Pazos (mail)
  • Paula Iglesias (mail)
  • Alexander Carneiro (mail)
  • Iñaki López (mail)
  • Rebeca Martínez (mail)
  • Anxo Nogueira (mail)
  • Ana Fernández

Staff

  • Merchi Rodríguez (mail)
  • Francesco di Martino (mail)
  • Pablo Barbeito
  • Agatha Carretero

Contact

Our labs can be found in three close locations at the As Lagoas-Marcosende campus of the University of Vigo:

  • School of Biology
    • Diana Valverde
  • School of Chemistry
    • Carmen Rodríguez-Argüelles
  • CINBIO
    • David Posada
    • Miguel Arenas
    • Iria Fernández-Silva
    • María Mayán

Phone: (+34) 986 130050
Email: xb5lab@gmail.com

News

Xunta de Galicia continues to support our group

We are proud to announce that the Xunta de Galicia continues to support the Genomics and Biomedicine Group (GXB) at the University of Vigo as a Competitive Reference Group within the Center for Biomedical Research (CINBIO), a Singular Research Center recognized by the Galician Government. This continued support enables us to advance our research in …

TALENTGAL (MSCA-COFUND) 40 postdoctoral fellowships

Excited about biomedical research? Come work with us! TALENTGAL (MSCA-COFUND) has 40 postdoc fellowships open NOW — 30 months, fully funded, interdisciplinary! 3 potential positions at CINBIO.• Molecular & Immune Mechanisms in Precision Oncology• AI-driven Biomedical Data Analysis• Multiomic Approaches for Next-Gen Therapeutics Deadline: July 23, 2026 Who Can Apply Applicants must meet the following …

New paper in Genome Medicine

New in Genome Medicine! Deep genomic analysis of relapsed colorectal cancer liver metastases reveals patient-specific evolutionary trajectories and multiple routes to recurrence. Laura Tomás at our lab led the hands‑on, multi‑omic analysis Nice collaboration with @soulafa.bsky.social & colleagues https://link.springer.com/article/10.1186/s13073-026-01614-0